The primary purpose of this study is to obtain measurements in objective measures of physical function, muscular strength, power, body composition and self-reported quality of life at baseline and 12 and 24 weeks after initiating androgen receptor signaling inhibitor treatment in men with metastatic prostate cancer.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
Erik Hanson
Exercise and Sport Science
Clinical or Medical
Observational
Aging
Cancer (Prostate)
22-1088